RadioBDC Logo
I See You | The Horrors Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
INNOVATION ECONOMY

Testing vaccine to block nicotine

Aaron Griset and Conlin O’Neil are part of a team at Selecta researching a vaccine that would train the immune system to block nicotine. Aaron Griset and Conlin O’Neil are part of a team at Selecta researching a vaccine that would train the immune system to block nicotine. (Bill Greene/Globe Staff)
By Scott Kirsner
Globe Correspondent / November 27, 2011
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

Selecta Biosciences, a Watertown company announced last week that it had begun the first clinical trial of SEL-068, a nicotine vaccine. In the same way a flu vaccine revs up your body’s immune system to round up flu viruses, Selecta’s vaccine would train the immune system to capture nicotine molecules in the bloodstream, barring them from entering your brain. Smoking a cigarette would have none of the calming, appetite-reducing, or focus-sharpening effects that smokers seek.

For more from BostonGlobe.com, sign up or log in below

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.